APA (7th ed.) Citation

Caroline Ingold, Paula Andrea Navarro, Renato de Oliveira, Caio Parente Barbosa, & Giuliano Bedoschi. (2023). Risk of ovarian hyperstimulation syndrome in women with malignancies undergoing treatment with long-acting gonadotropin-releasing hormone agonist after controlled ovarian hyperstimulation for fertility preservation: A systematic review. SAGE Publishing.

Chicago Style (17th ed.) Citation

Caroline Ingold, Paula Andrea Navarro, Renato de Oliveira, Caio Parente Barbosa, and Giuliano Bedoschi. Risk of Ovarian Hyperstimulation Syndrome in Women with Malignancies Undergoing Treatment with Long-acting Gonadotropin-releasing Hormone Agonist After Controlled Ovarian Hyperstimulation for Fertility Preservation: A Systematic Review. SAGE Publishing, 2023.

MLA (9th ed.) Citation

Caroline Ingold, et al. Risk of Ovarian Hyperstimulation Syndrome in Women with Malignancies Undergoing Treatment with Long-acting Gonadotropin-releasing Hormone Agonist After Controlled Ovarian Hyperstimulation for Fertility Preservation: A Systematic Review. SAGE Publishing, 2023.